Medline Q3 Adjusted EBITDA Rises 12% to $960 Million
Medline reported Q3 2026 adjusted EBITDA of $960 million, up 12%.
Related stories
Nigeria’s state oil company mulls IPO
The listing would be the second major energy IPO in Nigeria after that of the Dangote refinery, which sought to raise $1.6 billion. Nigeria’s state oil company NNPC could float up
H impact | EARNINGS | Nov 04, 2026, 02:23 PM UTC
Reynolds Consumer Products Reports 2026 Revenue of $944M, EPS of $0.28
Revenue rose 1.4% to $944M from $931M a year earlier; net income fell 26.6% to $58M and diluted EPS declined 26.3% to $0.28.
M impact | EARNINGS | Nov 04, 2026, 02:21 PM UTC
Smiths News Shares Fall 9% as Statutory Operating Profit Drops 16%
Smiths News shares were down around 9% at 74p by 1406 GMT after statutory operating profit fell 16% to £34.6m. Adjusted operating profit slipped 1% to £38.7m, slightly ahead of com
M impact | EARNINGS | Nov 04, 2026, 02:20 PM UTC
Stanley Black & Decker 3Q 2026 Net Earnings Rise to $272.1 Million
M impact | EARNINGS | Nov 04, 2026, 02:20 PM UTC
Par Pacific Forecasts 2026 Spending and Turnaround Costs of $190M-$220M
M impact | EARNINGS | Nov 04, 2026, 02:19 PM UTC
Aquestive Therapeutics Forecasts 2026 Revenue of $46 Million–$50 Million
M impact | EARNINGS | Nov 04, 2026, 02:19 PM UTC